| Date Filed | Type | Description |
| 05/25/2023 |
4
| MEANWELL CLIVE (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 01/04/2023 |
4
| MEANWELL CLIVE (Director) has filed a Form 4 on EQRx, Inc.|
Txns:
| Granted 226 options to buy
@ $0 |
|
| 10/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| MEANWELL CLIVE (10% Owner) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.09, valued at
$463.5k
|
|
| 03/30/2022 |
3
| MEANWELL CLIVE (See Explanation of Responses.) has filed a Form 3 on Adagio Therapeutics, Inc. |
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/25/2021 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on Population Health Investment Co., Inc.|
Txns:
| Bought 5,100 shares
@ $9.79, valued at
$49.9k
Bought 11,300 shares
@ $9.8, valued at
$110.7k
Bought 20,000 options to buy
@ $11.5, valued at
$230k
|
|
| 11/17/2020 |
3
| MEANWELL CLIVE (CEO) has filed a Form 3 on Population Health Investment Co., Inc. |
| 01/06/2020 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Disposed/sold 480,340 shares
@ $0
Disposed/sold 120,000 options
@ $30.55, valued at
$3.7M
Disposed/sold 234,375 options
@ $28.77, valued at
$6.7M
Disposed/sold 297,776 options
@ $33.04, valued at
$9.8M
Disposed/sold 210,793 options
@ $52.7, valued at
$11.1M
Disposed/sold 87,750 options
@ $29.01, valued at
$2.5M
Disposed/sold 117,000 options
@ $29.01, valued at
$3.4M
Disposed/sold 234,000 options
@ $29.01, valued at
$6.8M
Disposed/sold 95,000 options
@ $25.41, valued at
$2.4M
|
|
| 12/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/04/2019 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 491 shares
@ $21.6, valued at
$10.6k
|
|
| 04/26/2019 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Paid exercise price by delivering 2,796 shares
@ $30.48, valued at
$85.2k
|
|
| 03/06/2019 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Paid exercise price by delivering 3,063 shares
@ $25.53, valued at
$78.2k
Paid exercise price by delivering 3,586 shares
@ $25.53, valued at
$91.6k
Paid exercise price by delivering 2,962 shares
@ $25.53, valued at
$75.6k
|
|
| 03/04/2019 |
4
| MEANWELL CLIVE (Chief Innovation Officer) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 317 shares
@ $20.97, valued at
$6.6k
Granted 95,000 options to buy
@ $25.41, valued at
$2.4M
|
|
| 09/05/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 375 shares
@ $28.28, valued at
$10.6k
Sold 50,000 shares
@ $39.31, valued at
$2M
|
|
| 08/02/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 50,000 shares
@ $39.24, valued at
$2M
|
|
| 07/05/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 50,000 shares
@ $36.07, valued at
$1.8M
|
|
| 04/26/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 22,589 shares
@ $0 |
|
| 03/05/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Paid exercise price by delivering 22,287 shares
@ $33.29, valued at
$741.9k
|
|
| 03/02/2018 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 330 shares
@ $26.02, valued at
$8.6k
|
|
| 12/19/2017 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 136,250 shares
@ $27.24, valued at
$3.7M
Exercised 200,920 options to buy
@ $19.36, valued at
$3.9M
|
|
| 09/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/09/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/23/2016 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 8,623 shares
@ $40, valued at
$344.9k
Exercised 8,623 options to buy
@ $28.6, valued at
$246.6k
|
|
| 09/02/2016 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 378 shares
@ $28.08, valued at
$10.6k
Sold 1,377 shares
@ $40, valued at
$55.1k
Exercised 1,377 options to buy
@ $28.6, valued at
$39.4k
|
|
| 08/25/2016 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 20,000 shares
@ $40, valued at
$800k
Exercised 20,000 options to buy
@ $28.6, valued at
$572k
|
|
| 05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2016 |
4
| MEANWELL CLIVE (CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Granted 305 shares
@ $27.34, valued at
$8.3k
Granted 45,400 shares
@ $0
Paid exercise price by delivering 21,600 shares
@ $33.85, valued at
$731.2k
Granted 297,776 options to buy
@ $33.04, valued at
$9.8M
|
|
| 12/04/2013 |
4
| MEANWELL CLIVE (Chairman & CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 10,000 shares
@ $36.5764, valued at
$365.8k
|
|
| 10/03/2013 |
4
| MEANWELL CLIVE (Chairman & CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 7,500 shares
@ $33.45, valued at
$250.9k
|
|
| 09/05/2013 |
4
| MEANWELL CLIVE (Chairman & CEO) has filed a Form 4 on MEDICINES CO /DE|
Txns:
| Sold 7,500 shares
@ $31.85, valued at
$238.9k
|
|
|